Does postprandial blood glucose matter and why?

Endocrinologia y Nutricion

Volumn 56, Issue SUPPL. 4, 2009, Pages 8-11

  Ceriello, Antonio ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; ACARBOSE; AMYLIN DERIVATIVE; ANTIDIABETIC AGENT; GLIBENCLAMIDE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; INSULIN ASPART; INSULIN DERIVATIVE; REPAGLINIDE;

ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DRUG EFFECT; DYSLIPIDEMIA; ENDOTHELIAL DYSFUNCTION; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; IMPAIRED GLUCOSE TOLERANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; OXIDATIVE STRESS; PATHOPHYSIOLOGY; POSTPRANDIAL STATE; RISK FACTOR;

EID: 77953246155     PISSN: 15750922     EISSN: 15792021     Source Type: Journal    
DOI: 10.1016/S1575-0922(09)73508-9     Document Type: Article

References (40)

1. Ceriello A., Hanefeld M., Leiter L., Monnier L., Moses A., Owens D., et al. Postprandial glucose regulation and diabetic complications. Arch Intern Med 164 (2004) 2090-2095
2. De Vegt F., Dekker J.M., Ruhè H.G., Stehouwer C.D.A., Nijpels G.B.L.M., and Heine R.J. Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population : the Hoorn Study. Diabetologia 42 (1999) 926-931
3. Donahue R.P., Abbott R.D., Reed D.M., and Yano K. Postchallenge glucose concentration and coronary heart disease in men of Japanese ancestry. Honolulu Heart Program. Diabetes 36 (1987) 689-692
4. Lowe L.P., Liu K., Greenland P., Metzger B.E., Dyer A.R., and Stamler J. Diabetes, asymptomatic hyperglycemia, and 22-year mortality in black and white men. The Chicago Heart Association Detection Project in Industry Study. Diabetes Care 20 (1997) 163-169
5. The DECODE study group, on behalf of the European Diabetes Epidemiology Group. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. Lancet 354 (1999) 617-621
6. Coutinho M., Gerstein H.C., Wang Y., and Yusuf S. The relationship between glucose and incident cardiovascular events: a metaregression analysis of published data from 20 studies of 95,783 individuals followed fro 12.4 years. Diabetes Care 22 (1999) 233-240
7. Balkau B., Shipley M., Jarrett R.J., Pyörälä K., Pyörälä M., Forhan A., et al. High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study. Diabetes Care 21 (1998) 360-367
8. Hanefeld M., Fischer S., Julius U., Schulze J., Schwanebeck U., Schmechel H., et al., The DIS Group. Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up. Diabetologia 39 (1996) 1577-1583
9. Cavalot F., Petrelli A., Traversa M., Bonomo K., Fiora E., Conti M., et al. Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in type 2 diabetes mellitus, particularly in women: lessons from the San Luigi Gonzaga Diabetes Study. J Clin Endocrinol Metab 91 (2006) 813-819
10. Chiasson J.L., Josse R.G., Gomis R., Hanefeld M., Karasik A., Laakso M., and STOP-NIDDM Trail Research Group. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 359 (2002) 2072-2077
11. Chiasson J.L., Josse R.G., Gomis R., Hanefeld M., Karasik A., Laakso M., and STOP-NIDDM Trail Research Group. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. JAMA 290 (2003) 486-494
12. Zeymer U., Schwarzmaier-D'Assie A., Petzinna D., Chiasson J.L., and STOP-NIDDM Trial Research Group. Effect of acarbose treatment on the risk of silent myocardial infarctions in patients with impaired glucose tolerance: results of the randomised STOPNIDDM trial electrocardiography substudy. Eur J Cardiovasc Prev Rehabil 11 (2004) 412-415
13. Hanefeld M., Chiasson J.L., Koehler C., Henkel E., Schaper F., and Temelkova- Kurktschiev T. Acarbose slows progression of intimamedia thickness of the carotid arteries in subjects with impaired glucose tolerance. Stroke 35 (2004) 1073-1078
14. Hanefeld M., Cagatay M., Petrowitsch T., Neuser D., Petzinna D., and Rupp M. Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies. Eur Heart J 25 (2004) 10-16
15. Espósito K., Giugliano D., Nappo F., and Marfella R. Regression of carotid atherosclerosis by control of postprandial hyperglycemia in type 2 diabetes mellitus. Circulation 29 (2004) 2978-2984
16. Ceriello A. Postprandial hyperglycemia and diabetes complications: is it time to treat?. Diabetes 54 (2005) 1-7
17. Ceriello A., Bortolotti N., Motz E., Crescentini A., Lizzio S., Russo A., et al. Meal-generated oxidative stress in type 2 diabetic patients. Diabetes Care 21 (1998) 1529-1533
18. Ceriello A., Quagliaro L., Catone B., Pascon R., Piazzola M., Bais B., et al. Role of hyperglycemia in nitrotyrosine postprandial generation. Diabetes Care 25 (2002) 1439-1443
19. Ceriello A., Bortolotti N., Motz E., Pieri C., Marra M., Tonutti L., et al. Meal-induced oxidative stress and low-density lipoprotein oxidation in diabetes: the possible role of hyperglycemia. Metabolism 48 (1999) 1503-1508
20. Monnier L., Mas E., Ginet C., Michel F., Villon L., Cristol J.P., et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 295 (2006) 1681-1687
21. Ceriello A., Taboga C., Tonutti L., Quagliaro L., Piconi L., Bais B., et al. Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation: effects of shortand long-term simvastatin treatment. Circulation 106 (2002) 1211-1218
22. Ceriello A., Quagliaro L., Piconi L., Assaloni R., Da Ros R., Maier A., et al. Effect of postprandial hypertriglyceridemia and hyperglycemia on circulating adhesion molecules and oxidative stress generation and the possible role of simvastatin treatment. Diabetes 53 (2004) 701-710
23. Ceriello A. New insights on oxidative stress and diabetic complications may lead to a "causal" antioxidant therapy. Diabetes Care 26 (2003) 1589-1596
24. Assaloni R., Da Ros R., Quagliaro L., Piconi L., Maier A., Zuodar G., et al. Effects of S21403 (mitiglinide) on postprandial generation of oxidative stress and inflammation in type 2 diabetic patients. Diabetologia 48 (2005) 1919-1924
25. Ceriello A., Piconi L., Quagliaro L., Wang Y., Schnabel C.A., Ruggles J.A., et al. Effects of pramlintide on postprandial glucose excursions and measures of oxidative stress in patients with type 1 diabetes. Diabetes Care 28 (2005) 632-637
26. Manzella D., Grella R., Abbatecola A.M., and Paolisso G. Repaglinide administration improves brachial reactivity in type 2 diabetic patients. Diabetes Care 28 (2005) 366-371
27. Ceriello A., Cavarape A., Martinelli L., Da Ros R., Marra G., Quagliaro L., et al. The post-prandial state in type 2 diabetes and endothelial dysfunction: effects of insulin aspart. Diabet Med 21 (2004) 171-175
28. Shimabukuro M., Higa N., Takasu N., Tagawa T., and Ueda S. A single dose of nateglinide improves post-challenge glucose metabolism and endothelial dysfunction in Type 2 diabetic patients. Diabet Med 21 (2004) 983-986
29. Shimabukuro M., Higa N., Chinen I., Yamakawa K., and Takasu N. Effects of a single administration of acarbose on postprandial glucose excursion and endothelial dysfunction in type 2 diabetic patients: a randomized crossover study. J Clin Endocrinol Metab 91 (2006) 837-842
30. Scognamiglio R., Negut C., De Kreutzenberg S.V., Tiengo A., and Avogaro A. Effects of different insulin regimes on postprandial myocardial perfusion defects in type 2 diabetic patients. Diabetes Care 29 (2006) 95-100
31. Rudofsky Jr. G., Reismann P., Schiekofer S., Petrov D., Eynatten M., Humpert P.M., et al. Reduction of postprandial hyperglycemia in patients with type 2 diabetes reduces NF-kappaB activation in PBMCs. Horm Metab Res 36 (2004) 630-638
32. Taskinen M.R., Lahdenpera S., and Syvänne M. New insights into lipid metabolism in non-insulin-dependent diabetes mellitus. Ann Med 28 (1996) 335-340
33. Hamsten A., Björkegren J., Boquist S., Nilsson L., Ruotolo G., Eriksson P., et al. Postprandial lipaemia and coronary heart disease. Atherosclerosis 11 (1998) 141-149
34. Cavallero E., Dachet C., Neufcou D., Wirquin E., Mathe D., and Jacotot B. Postprandial amplification of lipoprotein abnormalities in controlled type II diabetic subjects: relationship to postprandial lipemia and C-peptide/glucagon levels. Metabolism 43 (1994) 270-278
35. Heine R.J., and Dekker J.M. Beyond postprandial hyperglycaemia: metabolic factors associated with cardiovascular disease. Diabetologia 45 (2002) 461-465
36. De Caterina R. Endothelial dysfunctions: common denominators in vascular disease. Curr Opin Lipidol 11 (2000) 9-23
37. Bae J.H., Bassenge E., Kim K.B., Kim Y.N., Kim K.S., Lee H.J., et al. Hypertriglyceridemia impairs endothelial function by enhanced oxidant stress. Atherosclerosis 155 (2001) 517-523
38. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 414 (2001) 813-820
39. Du X., Edelstein D., Obici S., Higham N., Zou M.H., and Brownlee M. Insulin resistance reduces arterial prostacyclin synthase and eNOS activities by increasing endothelial fatty acid oxidation. J Clin Invest 116 (2006) 1071-1080
40. Bonora E., Corrao G., Bagnardi V., Ceriello A., Comaschi M., Montanari P., et al. Prevalence and correlates of post-prandial hyperglycaemia in a large sample of patients with type 2 diabetes mellitus. Diabetologia 49 (2006) 846-854